10-121517379-A-G
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000141.5(FGFR2):c.1024T>C(p.Cys342Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 11/18 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C342F) has been classified as Pathogenic.
Frequency
Consequence
NM_000141.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGFR2 | ENST00000358487.10 | c.1024T>C | p.Cys342Arg | missense_variant | Exon 8 of 18 | 1 | NM_000141.5 | ENSP00000351276.6 | ||
FGFR2 | ENST00000613048.4 | c.757T>C | p.Cys253Arg | missense_variant | Exon 7 of 17 | 5 | ENSP00000484154.1 | |||
FGFR2 | ENST00000478859.5 | c.340T>C | p.Cys114Arg | missense_variant | Exon 7 of 17 | 1 | ENSP00000474011.1 | |||
FGFR2 | ENST00000457416.7 | c.1087+1303T>C | intron_variant | Intron 8 of 17 | 1 | ENSP00000410294.2 | ||||
FGFR2 | ENST00000369056.5 | c.1087+1303T>C | intron_variant | Intron 7 of 16 | 1 | ENSP00000358052.1 | ||||
FGFR2 | ENST00000369058.7 | c.1087+1303T>C | intron_variant | Intron 8 of 16 | 1 | ENSP00000358054.3 | ||||
FGFR2 | ENST00000369061.8 | c.749-2060T>C | intron_variant | Intron 5 of 14 | 1 | ENSP00000358057.4 | ||||
FGFR2 | ENST00000369059.5 | c.742+1303T>C | intron_variant | Intron 6 of 15 | 5 | ENSP00000358055.1 | ||||
FGFR2 | ENST00000360144.7 | c.820+1303T>C | intron_variant | Intron 7 of 16 | 2 | ENSP00000353262.3 | ||||
FGFR2 | ENST00000604236.5 | n.*71T>C | non_coding_transcript_exon_variant | Exon 7 of 17 | 1 | ENSP00000474109.1 | ||||
FGFR2 | ENST00000604236.5 | n.*71T>C | 3_prime_UTR_variant | Exon 7 of 17 | 1 | ENSP00000474109.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461878Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727238
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pfeiffer syndrome Pathogenic:3
This previously reported FGFR2 variant (rs121918488) is absent from large population datasets. Two submitters in ClinVar classify this variant as pathogenic. Multiple different missense changes have been reported in the same residue that have been shown to affect protein functionality. Two bioinformatic tools queried predict that the substitution would be possibly damaging, but these algorithms have low specificity, especially for predicting gain of function variants. This variant is considered pathogenic. -
- -
- -
not provided Pathogenic:3
- -
- -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 23754559, 9385368, 28901406, 8528214, 25759925, 7987400, 7719345, 25517871, 11343324, 8755573, 16418739, 11173845, 31837199, 12884424, 27228464, 24127277, 28600064, 29436723, 10633130, 10712195, 24656465, 10394936, 24411056, 27596331) -
FGFR2-related craniosynostosis Pathogenic:2
This sequence change replaces cysteine, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 342 of the FGFR2 protein (p.Cys342Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with Crouzon or Pfeiffer syndromes (PMID: 7987400, 12884424, 24127277, 25759925). ClinVar contains an entry for this variant (Variation ID: 13266). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt FGFR2 protein function with a positive predictive value of 95%. This variant disrupts the p.Cys342 amino acid residue in FGFR2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 24127277). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
Crouzon syndrome Pathogenic:2
- -
PM2_Supporting+PM5+PP3_Strong+PP2+PS2_Moderate+PS4+PP4 -
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis Pathogenic:2
- -
- -
Jackson-Weiss syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at